• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Introduction to 3,6-Dibromo-2,4-difluorobenzenesulfonamide (CAS No. 1803713-90-7)

3,6-Dibromo-2,4-difluorobenzenesulfonamide (CAS No. 1803713-90-7) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and agrochemical research due to its unique structural properties and potential applications. This compound belongs to the class of sulfonamides, which are widely recognized for their broad spectrum of biological activities. The presence of multiple halogen atoms (bromine and fluorine) in its molecular structure enhances its reactivity and makes it a valuable intermediate in synthetic chemistry.

The molecular formula of 3,6-Dibromo-2,4-difluorobenzenesulfonamide is C?H?Br?F?NO?S, reflecting its composition of carbon, hydrogen, bromine, fluorine, nitrogen, oxygen, and sulfur atoms. The sulfonamide functional group (-SO?NH?) is a key feature that contributes to its pharmacological properties. This group is known to interact with biological targets such as enzymes and receptors, making it a crucial component in drug design.

In recent years, the demand for halogenated sulfonamides has increased due to their role in developing novel therapeutic agents. 3,6-Dibromo-2,4-difluorobenzenesulfonamide has been studied for its potential as a precursor in the synthesis of various bioactive molecules. Its halogenated aromatic ring system provides a platform for further functionalization, enabling the creation of complex structures with tailored properties.

One of the most compelling aspects of 3,6-Dibromo-2,4-difluorobenzenesulfonamide is its utility in medicinal chemistry. Researchers have explored its derivatives as candidates for treating a range of diseases, including infectious disorders and chronic conditions. The bromine and fluorine substituents enhance the compound's lipophilicity and metabolic stability, which are critical factors in drug development.

The synthesis of 3,6-Dibromo-2,4-difluorobenzenesulfonamide involves multi-step organic reactions that require precise control over reaction conditions. The process typically begins with the bromination and fluorination of benzenesulfonyl chloride or benzenesulfonyl amide intermediates. Advanced catalytic methods have been employed to improve yield and selectivity during these transformations.

Recent advancements in computational chemistry have also played a pivotal role in understanding the behavior of 3,6-Dibromo-2,4-difluorobenzenesulfonamide. Molecular modeling studies have revealed insights into its interactions with biological targets, aiding in the design of more effective derivatives. These computational approaches are essential for predicting pharmacokinetic properties and minimizing potential side effects.

The agrochemical industry has also shown interest in 3,6-Dibromo-2,4-difluorobenzenesulfonamide, as sulfonamides are known to possess herbicidal and pesticidal properties. Derivatives of this compound have been investigated for their ability to inhibit weed growth without harming crops. This application highlights the versatility of sulfonamides as multifunctional compounds.

In conclusion,3,6-Dibromo-2,4-difluorobenzenesulfonamide (CAS No. 1803713-90-7) represents a significant advancement in synthetic chemistry and pharmaceutical research. Its unique structural features make it a valuable building block for developing novel therapeutic agents and agrochemicals. As research continues to uncover new applications for this compound,3,6-Dibromo-2,4-difluorobenzenesulfonamide is poised to play an increasingly important role in addressing global health challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)